Literature DB >> 12094098

Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides.

Margaret Anne Handley1, Arthur L Reingold, Stephen Shiboski, Nancy S Padian.   

Abstract

BACKGROUND: Acute urinary tract infection is one of the most common infections seen in primary care.
METHODS: We conducted a nested case-control study among a cohort of 519 women, ages 15-29 years, enrolled in a contraceptive acceptability study to examine whether recent use of male condoms increases urinary tract infection risk.
RESULTS: One hundred sixty-five incident urinary tract infections were identified during 12-month follow-up periods in a cohort study that was conducted between 1996 and 1999. After exclusions for urinary tract infection recurrences, pregnancy, antibiotic use, diabetes, diaphragm/cervical cap use, or urinary tract abnormalities, there were 100 cases and 200 controls. Compared with women not using barrier methods (and after adjustment for age, urinary tract infection history, hormonal method use, and frequency of sex) the odds ratio (OR) for any reported use of condoms coated with spermicide (Nonoxynol-9) in the previous 30 days was 2.8 (95% [confidence interval] CI = 1.2-6.5). The OR was 11.5 (95% CI = 2.5-53) for exclusive Nonoxynol-9-coated condom use. The OR for exclusive use of non-Nonoxynol-9-coated condoms was 7.4 (95% CI = 1.6-35).
CONCLUSIONS: In this study, use of male condoms was associated with increased urinary tract infection risk; the largest risk was associated with exclusive condom use and use of Nonoxynol-9-coated condoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094098     DOI: 10.1097/00001648-200207000-00011

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  9 in total

1.  Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Authors:  Shawn Dason; Jeyapandy T Dason; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 2.  Urinary tract infections in adult general practice patients.

Authors:  Eva Hummers-Pradier; Michael M Kochen
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

Review 3.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

Review 4.  Non-surgical management of recurrent urinary tract infections in women.

Authors:  Paul A Bergamin; Anthony J Kiosoglous
Journal:  Transl Androl Urol       Date:  2017-07

Review 5.  Nanotechnology and the future of condoms in the prevention of sexually transmitted infections.

Authors:  Clarence S Yah; Geoffrey S Simate; Percy Hlangothi; Benesh M Somai
Journal:  Ann Afr Med       Date:  2018 Apr-Jun

6.  Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection.

Authors:  A Mohammed Fayaz; Zhujun Ao; Morkattu Girilal; Liyu Chen; Xianzhong Xiao; Pt Kalaichelvan; Xiaojian Yao
Journal:  Int J Nanomedicine       Date:  2012-09-24

7.  Faecal Escherichia coli isolates show potential to cause endogenous infection in patients admitted to the ICU in a tertiary care hospital.

Authors:  D Nagarjuna; G Mittal; R S Dhanda; P K Verma; R Gaind; M Yadav
Journal:  New Microbes New Infect       Date:  2015-06-04

8.  Expert Panel Recommendations on Lower Urinary Tract Health of Women Across Their Life Span.

Authors:  Liliana Losada; Cindy L Amundsen; James Ashton-Miller; Toby Chai; Clare Close; Margot Damaser; Michael DiSanto; Roger Dmochowski; Matthew O Fraser; Stephanie J Kielb; George Kuchel; Elizabeth R Mueller; Candace Parker-Autry; Alan J Wolfe; Monica P Mallampalli
Journal:  J Womens Health (Larchmt)       Date:  2016-06-10       Impact factor: 2.681

9.  Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection.

Authors:  Ased S M Ali; Catherine Mowbray; Marcelo Lanz; Anna Stanton; Samantha Bowen; Claire L Varley; Paul Hilton; Karen Brown; Wendy Robson; Jennifer Southgate; Phillip D Aldridge; Alison Tyson-Capper; Soman Abraham; Robert S Pickard; Judith Hall
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.